Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Amazon Great Indian Festival 2020 - Electronics
Stock Report

| More

Edelweiss AMC partners with MSCI to launch its first Thematic Index fund in India

Posted On: 2020-10-05 00:40:18


Edelweiss Asset Management Limited, one of India's fastest growing AMCs, today announced a partnership with MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, to launch Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund. This launch marks MSCI's foray into the Indian market and the NFO will be open from October 6, 2020 to October 20, 2020. First in a series of collaborations between Edelweiss and MSCI, this thematic passive index fund is designed with the objective of providing Indian investors undiluted access to invest in top healthcare companies from India and around the world.

Benefiting from growth drivers like growing demand, export opportunities and a conducive policy environment, this fund will be a winning combination of innovation and growth, with exposure to some of the world's largest healthcare companies listed in the US and India's fast-growing healthcare market. 70% of the fund's weightage is on Indian Healthcare, comprising top 25 stocks based on full market cap. The remaining 30% weightage will be on 20 stocks listed in the US, which comprise top 5 stocks based on full market cap from 4 sub-industries each - Pharmaceuticals, Healthcare Equipment, Biotechnology and Life Sciences Tools and Services. A few of the top holdings of the underlying fund include Apollo Hospitals, CIPLA, Dr. Reddy's Laboratories, Jubilant Life science, Biocon Ltd., and PFIZER.

Radhika Gupta, MD & CEO, Edelweiss Asset Management Limited commented, "We are pleased to partner with MSCI, a global leader in indices, which has a proven track record of strong governance and robust processes. This partnership with MSCI is consistent with Edelweiss AMC's legacy of building strong and sustainable alliances, much like the one with JP Morgan in 2016 and more recently with the Government of India on the Bharat Bond ETF, India's first corporate bond, launched in 2019.

We believe that this fund will provide investors with an easy, low cost and undiluted access to promising healthcare companies in India and around the world. Given the rise in lifestyle diseases and the uptick in spending to treat them, the healthcare sector is primed to grow steadily over the next decade."

Jack Lin, Managing Director and Head of APAC Client Coverage, MSCI, said, "We are proud to support Edelweiss AMC in their drive to deliver cutting-edge investment products to the Indian domestic market to meet the evolving needs of investors. The collaboration with Edelweiss AMC is a testament to MSCI's commitment to provide the emerging and fast-growing domestic investor base in India with world-leading solutions to better understand investment opportunities and risk, enabling them to build more effective and sustainable portfolios."

The initial investment in the fund will be Rs. 5,000/- per application with multiples of Re 1/-subsequently, with no exit load. The fund will be benchmarked against the MSCI India Domestic & World Healthcare 45 Index and managed by Hardik Varma for domestic investments and Mayur Dharmshi for overseas investments.

Shares of Edelweiss Financial Services Ltd. was last trading in BSE at Rs.58.85 as compared to the previous close of Rs. 58.85. The total number of shares traded during the day was 34713 in over 382 trades.

The stock hit an intraday high of Rs. 59.65 and intraday low of 58.6. The net turnover during the day was Rs. 2051374.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com

Amazon Great Indian Festival 2020 - Mobiles





Other Headlines:

GIGAnet from Vi is the most consistent and fastest 4G network in India: Ookla®

Fineotex Chemical Ltd Q2 consolidated PAT climbs to Rs. 10.48 crore

Sun Pharma announces 5-Year Sustained Efficacy and Safety Results for ILUMYA® (tildrakizumab-asmn) in Patients with Moderate-to-Severe Plaque Psoriasis

Rushil Decor Limited calls for call money payment towards partly paid equity shares

NXTDIGITAL LIMITED divests 80,78,155 shares of Hinduja Leyland Finance Ltd

Virinchi Limited to launch Mobile App based Pharmacy

Trishan Metals Private Limited becomes 100% subsidiary of IFB Industries Ltd

S&P reaffirms AXIS Bank's issuer credit rating

Aditya Vision Ltd opens 55th showroom at Jhanjharpur, Madhubani

Rushil Decor Limited's new Andhra unit commercial operation pushed to April 1, 2021

IDFC First Bank Ltd posts consolidated PAT of Rs. 109.02 crore in Q2FY2021

Likhitha Infrastructure Ltd Q2 net profit jumps to Rs. 5.36 crore

Tanla Platforms Ltd Q2 consolidated PAT up at Rs. 81.47 crore

Colinz Laboratories Ltd Q2FY21 PAT at Rs. 0.0644 crore

Unick Fix-A-Form And Printers Ltd posts PAT of Rs. 0.69 crore in Q2

DCB Bank Ltd reports Rs. 82.29 crore net profit in Q2FY21

ICICI Bank Ltd Q2FY21 consolidated PAT jumps to Rs. 4882.33 crore

Sheela Foam Ltd Q2 consolidated PAT soars to Rs. 69.84 crore

Yash Pakka Ltd Q2FY21 net profit higher at Rs. 3.17 crore

Rushil Decor Ltd Q2FY21 PAT surges QoQ to Rs. 6.81 crore

Relaxo Footwears Q2FY21 PAT climbs to Rs. 75.10 crore

Punit Commercials Ltd posts PAT of Rs. 0.23 crore in Q2

Nitin Spinners Ltd Q2FY21 PAT up at Rs. 11.92 crore

Unichem Laboratories Ltd Q2FY21 consolidated net profit rises to Rs. 8.73 crore

Paisalo Digital Ltd reports jump in Q2FY21 consolidated PAT to Rs. 21.94 crore

ZEN Technologies Ltd Q2 consolidated PAT at Rs. 0.78 crore

Divyashakti Granites Ltd posts Rs. 1.54 crore PAT in Q2FY21

PNB Gilts Ltd board to consider Q2 results, interim dividend on Nov 10, 2020

The Anup Engineering Ltd Q2FY21 net profit at Rs. 11.66 crore

JSW Holdings Ltd Q2FY21 consolidated PAT at Rs. 39.48 crore

SKP Securities Ltd Q2FY21 net profit at Rs. 0.60 crore

Hester BioSciences Ltd Q2FY21 consolidated net profit up at Rs. 6.68 crore

Deepak Nitrite Limited reports earnings for Q2FY21, H1FY21

Zuari Agro Chemicals Ltd board to consider Q2FY21 results on Nov 9, 2020

Chalet Hotels Ltd board to announce Q2FY21 results on Nov 10, 2020

Aarti Drugs Ltd to expand Metformin Capacity to 3000 TPM

Nectar Lifesciences Ltd posts consolidated loss of Rs. 7.31 crore in Q2FY21

Wheels India Ltd Q2FY21 consolidated PAT at Rs. 6.84 crore

Quess Corp Ltd reports Q2FY21 consolidated PAT of Rs. 45.68 crore

Ador Multiproducts Ltd Q2 consolidated PAT zooms to Rs. 3.31 crore

Edelweiss Financial Services Ltd Q2FY21 consolidated loss at Rs. 48.50 crore

Wheels India Ltd commissions new plant at Thervoykandigai

Grasim Industries Limited and Lubrizol Partner for India's largest CPVC Resin Plant

WEP Solutions Ltd board to consider Q2FY21 results, rights issue on Nov 6, 2020

Motilal Oswal Financial Services Ltd posts consolidated net profit of Rs. 296.46 crore in Q2

Deepak Nitrite Ltd Q2FY21 consolidated net profit rises to Rs. 170.19 crore

Voith Paper Fabrics India Ltd reports net profit of Rs. 7.94 crore in Q2

RIL Q2FY21 consolidated net profit declines to Rs. 9567 crore

Emkay Global Financial Services Ltd posts Rs. 3.67 crore consolidated PAT in Q2FY21

Aarti Surfactants Ltd board to consider raising capital, Q2 results on Nov 5, 2020







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019